"Effects of Serum from a Fibrodysplasia Ossificans Progressiva Patient on Osteoblastic Cells"
written by Itoko Hisa, Akira Kawara, Takenobu Katagiri, Toshitsugu Sugimoto, Hiroshi Kaji,
published by Open Journal of Endocrine and Metabolic Diseases, Vol.2 No.1, 2012
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification
2018
[2] Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice
Journal of bone and mineral metabolism, 2015
[3] фибродисплазия у детей (обзор литературы и анализ пяти клинических случаев)
2015
[4] Прогрессирующая оссифицирующая фибродисплазия у детей (обзор литературы и анализ 5 клинических случаев)
2014
[5] Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues
2014
[6] Interaction between Muscle and Bone
Journal of bone metabolism, 2014
[7] Alternative formats
H Kaji - synapse.koreamed.org, 2014
[8] Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues.
Journal of Biological Chemistry, 2014
[9] Linkage between muscle and bone: common catabolic signals resulting in osteoporosis and sarcopenia
Current Opinion in Clinical Nutrition & Metabolic Care, 2013
[10] Sarcopenia: definition, epidemiology, and pathophysiology
Journal of bone metabolism, 2013
[11] Serum bisphenol A concentration in postmenopausal women with osteoporosis
Journal of bone metabolism, 2012